Company profile
ImmunoACT
India's Leader in Cell & Gene Therapies
- Industry
- Biotechnology Research
- Employees
- 196
- Headquarters
- Navi Mumbai, Maharashtra
- Founded
- 2018
- LinkedIn followers
- 37,885
- Office locations
- 1
ImmunoACT company summary
ImmunoACT is a company in the Biotechnology Research industry, headquartered in Navi Mumbai, Maharashtra, founded in 2018. On LinkedIn the company has around 196 employees and 37,885 followers. Its listed specialties include Cell & Gene Therapies, Translational Research, Viral Vector Process Development & Manufacturing.
What technology does ImmunoACT use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ImmunoACT
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.
Specialties
Where is ImmunoACT located?
ImmunoACT lists 1 location.
Compare companies similar to ImmunoACT
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ImmunoACT immunoact.com | Biotechnology Research | 196 | 2018 | Navi Mumbai, Maharashtra |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ImmunoACT
What does ImmunoACT do?
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.
How many employees does ImmunoACT have?
ImmunoACT has around 196 employees on LinkedIn.
Where is ImmunoACT headquartered?
ImmunoACT is headquartered in Navi Mumbai, Maharashtra.
When was ImmunoACT founded?
ImmunoACT was founded in 2018.
Build a lead list from companies like ImmunoACT
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.